TGI

TRV GP II Portfolio holdings

AUM $1.34M
This Quarter Return
+43.18%
1 Year Return
-67.55%
3 Year Return
-19.8%
5 Year Return
-49.56%
10 Year Return
–
AUM
$534M
AUM Growth
+$534M
Cap. Flow
-$180M
Cap. Flow %
-33.7%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

1
MYOK
MyoKardia, Inc. Common Stock
MYOK
$97.6M
2
SAGE
Sage Therapeutics
SAGE
$82.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
JNCE
1
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$229M 42.85%
10,230,349
– –
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$225M 42.17%
2,453,753
– –
MYOK
3
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$43.2M 8.09%
885,104
-2,000,000
-69% -$97.6M
ALNA
4
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$30.8M 5.76%
2,790,964
– –
SAGE
5
DELISTED
Sage Therapeutics
SAGE
$6.02M 1.13%
37,362
-510,554
-93% -$82.2M